Target intelligence / Profile preview

Signal transducer and activator of transcription 5A (STAT5A) mRNA (STAT5A mRNA)

Target
STAT5A mRNA
Molecular classification
Messenger RNA, Transcription factor (encoded protein), JAK-STAT signaling pathway component
01

Overview

Signal transducer and activator of transcription 5A (STAT5A) mRNA is the transcript encoding the STAT5A protein, a key transcription factor in the JAK-STAT signaling pathway. STAT5A is essential for mediating the cellular response to various cytokines and growth factors, such as interleukin-3 and erythropoietin, thereby regulating hematopoiesis, immune cell activation, and mammary gland development (UniProt P42229). In many cancers, particularly leukemias and certain solid tumors, STAT5A is constitutively activated or overexpressed, driving uncontrolled cell proliferation and survival (NCBI Gene 6776). Targeting the STAT5A mRNA using antisense oligonucleotides (ASOs) or RNA interference (RNAi) provides a method to silence the gene and deplete the protein product, which has historically been difficult to target with small molecules due to the lack of traditional druggable pockets. For example, the antisense oligonucleotide ISTH-0035 has been investigated for its ability to downregulate STAT5 expression in hematological malignancies (Isarna Therapeutics). Therapeutic challenges include ensuring specific delivery to target tissues and managing potential toxicities related to the inhibition of STAT5A's normal physiological roles in blood cell production.

Other names
STAT5A transcriptMammary gland factor (MGF) mRNASignal transducer and activator of transcription 5A transcript
02

Mechanism of action

Antisense oligonucleotide-mediated degradation of mRNA via RNase H activation, leading to reduced protein expression.

03

Biological functions

Signal transductionCell proliferationCell differentiationApoptosis regulationImmune responseHematopoiesis
04

Disease associations

Acute myeloid leukemiaChronic myeloid leukemiaBreast cancerProstate cancerLymphomaInflammatory diseases
05

Safety considerations

Potential for myelosuppressionOff-target effects of oligonucleotidesInnate immune activationDelivery challenges to bone marrow or solid tumors
06

Interacting drugs

ISTH-0035
07

Biomarkers

STAT5A mRNA expression levelsPhospho-STAT5A (pSTAT5A) protein levelsJAK2 mutation statusBCR-ABL1 fusion status

Beyond the preview

Go deeper on Signal transducer and activator of transcription 5A (STAT5A) mRNA (STAT5A mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal transducer and activator of transcription 5A (STAT5A) mRNA (STAT5A mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call